Kiromic BioPharma Inc (KRBP)
3.11
+0.03
(+0.97%)
USD |
OTCM |
May 17, 13:42
Kiromic BioPharma Shareholders Equity (Quarterly): -7.212M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -7.212M |
| December 31, 2023 | -9.121M |
| September 30, 2023 | -4.487M |
| June 30, 2023 | -6.295M |
| March 31, 2023 | -8.140M |
| December 31, 2022 | -5.775M |
| September 30, 2022 | 0.2841M |
| June 30, 2022 | 11.78M |
| March 31, 2022 | 20.03M |
| Date | Value |
|---|---|
| December 31, 2021 | 27.32M |
| September 30, 2021 | 37.51M |
| June 30, 2021 | 4.872M |
| March 31, 2021 | 8.453M |
| December 31, 2020 | 11.36M |
| September 30, 2020 | 0.9286M |
| June 30, 2020 | 2.095M |
| March 31, 2020 | 3.582M |
| December 31, 2019 | 1.979M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-9.121M
Minimum
Dec 2023
37.51M
Maximum
Sep 2021
4.954M
Average
2.037M
Median
Shareholders Equity (Quarterly) Benchmarks
| Lisata Therapeutics Inc | 43.00M |
| Achieve Life Sciences Inc | 49.46M |
| Syra Health Corp | 3.449M |
| CEL-SCI Corp | 14.30M |
| AIM ImmunoTech Inc | 10.23M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.63M |
| Total Liabilities (Quarterly) | 19.84M |